Objective: Giant cell arteritis (GCA) can cause ischemic stroke (IS) due to the involvement of the internal carotid and vertebral arteries. The aim of our study is to describe the pattern of stroke recurrence in patients with GCA-related IS and the role of vascular imaging in the follow-up of these patients.
Methods: We conducted an observational study of 2417 consecutive patients diagnosed with IS and admitted to our hospital from January 2012 to December 2018. We reviewed patients with GCA-related IS and the relationship of erythrocyte sedimentation rate, C-reactive protein, vascular status, and clinical course.
Results: We found 4 patients with GCA-related IS among 2417 IS patients: 1 woman (25%); median age, 77.3 years (67-85 years). Mean follow-up was 3.6 years. Initial vascular workup showed vertebral artery stenosis in all of them and internal carotid artery stenosis in 2 patients. All patients were started on treatment with full-dose prednisone, associated with methotrexate in 2 cases. Follow-up color-coded duplex sonography disclosed progression of arterial stenoses in 3 patients who suffered a recurrent IS (days after index stroke; mean, 27.67 [SD, 10.97]) despite normal C-reactive protein and erythrocyte sedimentation rate values.
Conclusions: Vascular imaging, especially with color-coded duplex sonography, could play a role in the follow-up of patients with GCA-related IS and identify those patients with higher risk of recurrent stroke.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/RHU.0000000000001498 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cytotoxic CX3CR1+ T cells drive vascular inflammation in giant cell arteritis but not in Takayasu's arteritis.
Clin Exp Rheumatol
October 2024
Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Article Synopsis
- The study aimed to investigate the differences in cytotoxic CX3CR1+ T cell subsets between two types of large vessel vasculitis: giant cell arteritis (GCA) and Takayasu's arteritis (TAK).
- Scientists analyzed blood samples from 30 patients (22 with GCA and 8 with TAK) and 16 healthy individuals to compare the proportion of CX3CR1+ CD4+ and CD8+ T cells, as well as their presence in inflamed arteries.
- The results reveal a significant increase in CX3CR1+ CD4+ T cells in GCA, associated with inflammation severity, while no such correlation was found in TAK, suggesting that these cells play a crucial role
Antiplatelet therapy to prevent ischemic events in giant cell arteritis: protocol for a systematic review and meta-analysis.
Syst Rev
July 2024
Vasculitis Clinic, Hopital Sacre-Coeur, University of Montreal, Canadian Vasculitis Research Network, 5400 Bd Gouin O, Montreal, QC, H4J1C5, Canada.
Background: Giant cell arteritis (GCA) is the most common systemic vasculitis in adults. Presenting features include new-onset headaches, constitutional symptoms, jaw claudication, polymyalgia rheumatica, and visual symptoms. Arterial inflammation with subsequent stenosis and occlusion may cause tissue ischemia, leading to blindness, strokes, and myocardial infarction.
View Article and Find Full Text PDFAltered Plasma Levels and Tissue Expression of Fibroblast Activation Protein Alpha in Giant Cell Arteritis.
Arthritis Care Res (Hoboken)
September 2024
Department of Rheumatology and Clinical Immunology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Article Synopsis
- The study focuses on giant cell arteritis (GCA), a condition causing inflammation in large arteries, and investigates the role of fibroblast activation protein alpha (FAP), which is linked to inflammation and tissue changes.* -
- Plasma levels of FAP were found to be lower in GCA patients compared to those with polymyalgia rheumatica (PMR) and healthy controls, with levels decreasing further during remission and eventually rising near healthy levels during treatment-free remission.* -
- The research indicates that FAP is highly expressed in inflamed tissues of GCA patients and may play a key role in the disease's inflammatory and remodeling processes, suggesting it could be a potential target for future imaging and therapy.*
Evolution and outcomes of aortic dilations in giant cell arteritis.
Eur J Intern Med
November 2024
Department of Internal Medicine, Caen University Hospital, Caen, France; University of Caen Normandie, Caen, France. Electronic address:
Article Synopsis
- The study aimed to identify factors contributing to the progression of aortic dilations in patients with giant cell arteritis (GCA).
- Among 47 analyzed patients, 28% experienced fast-progressive aortic dilations, while 34% had slow-progressive and 38% were not progressive, with no significant differences in baseline characteristics across these groups.
- Fast-progressive patients were more likely to have atheromatous disease and used statins and antiplatelet agents more frequently; inflammation in the aorta was linked to dilation in the majority of patients with GCA-related aortitis.
Frequency and characteristics of severe relapse in giant cell arteritis.
Rheumatology (Oxford)
March 2024
Department of Internal Medicine, Caen University Hospital, Caen, France.
Objectives: To assess the frequency and characteristics of severe relapse in patients with giant cell arteritis (GCA) in a real-life setting.
Methods: In a monocentric database of 530 patients, we retrospectively analysed patients who experienced at least one relapse and distinguished severe from nonsevere relapses. Severe relapse was defined by the occurrence of an ischaemic event (ophthalmologic, neurologic, digestive, limb ischaemia), the occurrence of an aortic complication (i.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!